Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
calcitonin gene-related peptide
chronic migraine
clinical trials
eli lilly
episodic migraine
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
alder biopharmaceuticals
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
business
business sponsored company news
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
indiana
institute for clinical and economic review
migraine
migraine research foundation
migraines
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
What
medicines
3
×
new
pain
3
×
approval
class
developed
drug
fda
migraine
starts
won
agency
amgen
announced
announces
approved
candidates
chemical
cns
committee
company
decision
designation
development
eli
entity
european
focused
gets
head
headache
late
lilly
marks
medicinal
newron
nod
novel
opinion
orphan
Language
Current search:
medicines
×
pain
×
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@venturebeat.com
9 years ago
Newron Receives Positive Opinion for Orphan Medicinal Product Designation for Sarizotan to Treat Patients with Rett Syndrome from the Committee for Orphan Medicinal Products from the European Medicines Agency